Oblinger Michael J MD is categorized under Medical Research in Charlottesville, VA and active since 1982.
Oblinger Michael J MD was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Oblinger at the company’s single location by writing to 1139 East High St # 203, Charlottesville, Virginia VA 22902 or by phoning (434) 817-8484. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oblinger Michael J MD |
| Contact Person: | Michael Oblinger |
| Address: | 1139 East High St # 203, Charlottesville, Virginia 22902 |
| Phone Number: | (434) 817-8484 |
| Website Address: | cvillegi.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6211110 |
| Share This Business: |
Oblinger Michael J MD was started in 1982 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Oblinger for inquiries that concern Oblinger Michael J MD by calling the company number (434) 817-8484, as your correspondence is most welcome. Additionally, the physical location of the single location of Oblinger Michael J MD can be found at the coordinates 38.03202,-78.46734 as well as the street address 1139 East High St # 203 in Charlottesville, Virginia 22902.
For its online presence, you may visit Oblinger Michael J MD’s website at cvillegi.com and engage with its social media outlets through on Twitter and on Facebook.